Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
522208
Reference Type
Journal Article
Title
Fighting drug dependence by blocking cannabinoid type 1 receptors
Author(s)
Singh, J; Budhiraja, S
Year
2007
Is Peer Reviewed?
1
Journal
Pakistan Journal of Medical Sciences
ISSN:
1682-024X
EISSN:
1681-715X
Volume
23
Issue
3
Page Numbers
454-459
Language
English
Abstract
Drug dependence is a chronic relapsing brain disorder characterized by neurobiological changes that lead to a compulsion to take a drug with loss of control over drug intake. Abused drugs (cannabinoids, opioids, ethanol, nicotine and psychostimulants) by interacting with various neural pathways in brain induces pleasant state and responsible for relapses. All abused drugs have common property of elevating dopamine levels in nucleus accumbens. Currently the treatments available for drug dependence are not satisfactory and the most successful smoking cure clinic by using a combination of treatments achieve a success rate of less than 30%. Cannabinoid receptors are coexpressed in the brain reward circuitry and recent preclinical and human studies have suggested that ligands blocking the CB1 receptors offer a novel approach for patients suffering from drug dependence that may be efficacious across different classes of abused drugs. This review examines the role and current status of cannabinoid CB1 receptor antagonist in drug dependence.
Keywords
drug dependence; CB1 receptor; SR141716A; dopamine d2 receptors; nucleus-accumbens; knockout mice; endocannabinoid system; cb1; rats; antagonist; nicotine; addiction; morphine
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity